Rihani Rawad, Jeha Sima, Nababteh Mayse, Rodriguez-Galindo Carlos, Mansour Asem, Sultan Iyad
Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Front Oncol. 2023 Mar 24;13:1112788. doi: 10.3389/fonc.2023.1112788. eCollection 2023.
Jordan hosts one of the highest numbers of refugees per capita in the world, with the Syrian crisis leading to an influx of displaced persons to the already vulnerable population. However, limited resources and a lack of cancer-care strategies have made it difficult for refugees in Jordan to access quality cancer care. The King Hussein Cancer Center (KHCC) and Foundation (KHCF) have played a pivotal role in providing financial and medical support for displaced children with cancer, treating 968 non-Jordanian children with cancer between 2011-2022, with a median age of 6 years. Of these, 84% were fully funded by KHCF, and nationalities included Syrians (29%), Palestinians (26%), Iraqis (23%), and Yemenis (17%). Cancer diagnoses included solid tumors (44%), leukemia (23%), lymphoma (13%), bone sarcomas (9.5%), and retinoblastoma (9.1%). The median cost of treatment was JOD 18,000 (USD 25,352), with a total estimated cost of JOD 23.8 million (USD 33.5 million). More recently, in partnership with St. Jude Children's Research Hospital (SJCRH), two successive humanitarian funds (HF) were established to optimize cancer care for displaced children in Jordan.
Between February 2018 and September 2022, 51 children were fully treated on KHCC-SJCRH-HF, with a median age of 6 years and nationalities including Syrians (80%), Iraqis (6%), and Yemenis (8%). The most common cancer diagnoses were leukemia (41%), lymphoma (25%), solid tumors (24%), retinoblastoma (6%), and brain tumors (4%). Of these, 94% are alive and 51% are still receiving coverage. The median coverage for patients was JOD 21,808 (USD 30,715), and the total cost of treatment on KHCC/KHCF-SJCRH/American Lebanese Syrian-Associated Charities HF1 and HF2 was JOD 1.44 million (USD 1.97 million) and JOD 1.18 million (USD 1.67 million), respectively.
This experience highlights the high burden of displaced children with cancer in Jordan, and the importance of local foundations like KHCC/KHCF and partnerships with international partners like SJCRH in providing lifesaving humanitarian initiatives and quality cancer care. Innovative cancer-care delivery models and sustainable financing are essential to ensure continuous coverage and access to cancer care for displaced persons in Jordan.
约旦是世界上人均难民数量最多的国家之一，叙利亚危机导致流离失所者涌入本就脆弱的人口群体。然而，资源有限以及缺乏癌症护理策略，使得约旦的难民难以获得高质量的癌症护理。侯赛因国王癌症中心（KHCC）和基金会（KHCF）在为患癌流离失所儿童提供资金和医疗支持方面发挥了关键作用，在2011年至2022年期间治疗了968名非约旦籍患癌儿童，中位年龄为6岁。其中，84%由KHCF全额资助，国籍包括叙利亚人（29%）、巴勒斯坦人（26%）、伊拉克人（23%）和也门人（17%）。癌症诊断包括实体瘤（44%）、白血病（23%）、淋巴瘤（13%）、骨肉瘤（9.5%）和视网膜母细胞瘤（9.1%）。治疗的中位费用为18,000约旦第纳尔（25,352美元），总估计费用为2380万约旦第纳尔（3350万美元）。最近，与圣裘德儿童研究医院（SJCRH）合作，设立了两个连续的人道主义基金（HF），以优化约旦流离失所儿童的癌症护理。
在2018年2月至2022年9月期间，51名儿童在KHCC - SJCRH - HF接受了全程治疗，中位年龄为6岁，国籍包括叙利亚人（80%）、伊拉克人（6%）和也门人（8%）。最常见的癌症诊断是白血病（
